A denied TSH claim rarely comes from ordering the wrong test. It comes from a coding step that looked routine and got skipped. CPT code 84443 is one of the most-billed lab codes in any practice that touches thyroid care, and that familiarity is exactly why small errors slip through: a diagnosis code too vague to prove medical necessity, a repeat draw that ran past a payer’s frequency limit, a reflex panel billed with the wrong pairing.
This guide breaks down 84443 and the codes it travels with: Free T4, free T3, thyroid antibodies, imaging, biopsy, and the ICD-10 codes that back them up, along with the specific rules that cause denials.
CPT code 84443 reports one lab test: Measuring thyroid-stimulating hormone (TSH) in a patient’s blood. It’s the standard first-line test for hypothyroidism, hyperthyroidism, and monitoring thyroid replacement therapy, filed under Pathology and Laboratory, Chemistry Procedures.
A few details that change how the claim gets paid:
TSH is the screening test, but a full thyroid workup pulls in several adjacent codes, each billed separately even when a lab groups them under one order name.
A few pairing rules matter more than the codes themselves:

Many labs run a reflex protocol: TSH goes first, and if the result falls outside a set range, commonly below roughly 0.30 or above roughly 5.33 µIU/mL, though the exact cutoff is lab-specific, Free T4 gets added automatically, and both codes get billed.
Pros:
Cons:
CPT 76536 covers a thyroid ultrasound. It’s real-time imaging of the soft tissues of the head and neck, thyroid, parathyroid, and parotid glands with images saved to the record.
It’s a single code. Some billing tools list a separate “76537” for a limited or follow-up scan, but that split doesn’t appear in AAPC’s code set or in payer coverage policies; 76536 covers both a full exam and a focused follow-up on a known nodule. Worth double-checking against the current AMA code book before that distinction goes into a claim.
Coverage depends on medical necessity: A palpable mass, an abnormal thyroid lab result, or monitoring a known nodule typically qualify. A scan with no documented reason behind it is a common denial. If the same visit includes an ultrasound-guided biopsy, the guidance component (76942) bills separately from 76536; one covers the diagnostic scan, the other covers the procedure.
Two codes cover a thyroid biopsy, and the difference is the needle type. Fine needle aspiration with ultrasound guidance bills as 10005 for the first nodule and 10006 for each additional nodule; a core needle biopsy bills as 60100.

The right ICD-10 code depends on whether a diagnosis has already been confirmed. R94.6 (abnormal results of thyroid function studies) applies before a specific condition is confirmed. E03.9 (hypothyroidism, unspecified) or E05.90 (hyperthyroidism/thyrotoxicosis, unspecified) apply once the labs and symptoms support an actual diagnosis.
This is the single most common gap coders run into: Billing R94.6 after the chart already documents a confirmed hypothyroidism diagnosis. Once E03.9 applies, R94.6 shouldn’t carry the claim anymore.
Documentation needs to support whichever code gets used. A TSH value alone rarely counts on its own; the note should tie the number to a symptom, a monitoring reason, or a confirmed diagnosis. AAPC’s R94.6 reference is a useful bookmark for this exact distinction, since payers audit it more than most practices expect.
Yes, Z13.29 (encounter for screening for other suspected endocrine disorder) applies when a patient has no thyroid symptoms and no prior diagnosis, and the test is ordered as a preventive check.
Z13.29 only fits a true screening visit. If the patient reports fatigue, weight change, or another thyroid-related symptom, that symptom code should lead the claim instead. Some payers process wellness-visit thyroid testing differently from a symptom-driven order, so the diagnosis on file needs to match what actually happened in the visit, not just what got tested.
A gold-top serum separator tube (SST) is the standard collection tube for a TSH draw. Some labs also accept a green-top (lithium heparin) tube when serum isn’t available.
The sample needs to clot, get centrifuged, and stay refrigerated until it reaches the lab. A rejected or hemolyzed specimen means a redraw, which can trigger the frequency-limit issue covered earlier in this guide if it happens more than once in a short window. Getting this step right at the draw station is a quieter way to protect the claim than any coding fix downstream.
Most of what denies a TSH claim isn’t the test itself. It’s a frequency rule, a bundling edit, or a diagnosis code that doesn’t quite match the chart. None of that needs a coding overhaul to fix; it needs a team that catches the pattern before the claim goes out.
If thyroid panel denials keep showing up in your aging report, HelloMDs denial management team can run a free billing review and show exactly where the pattern starts.
Yes, and typically more than twice. Medicare's baseline is generally two tests a year for a stable patient, with more allowed when the chart documents a therapy change or new symptoms.
No modifier is required for TSH (84443) and Free T4 (84439) on the same date; they're commonly billed together. The modifier issue shows up with 84436 (Total T4), which can't be billed alongside 84439 at all.
84443 measures TSH, the pituitary hormone that regulates the thyroid. 84436 measures total T4, a hormone the thyroid itself produces. Different glands, different tests, different codes.
Medicare requires a diagnosis that supports medical necessity, not one fixed code. R94.6, E03.9, E05.90, and Z13.29 each fit a different clinical situation; the chart needs to support whichever one gets billed.
No. Panel 80050 already includes TSH along with a metabolic panel and a CBC. Billing 84443 separately for the same date and encounter is a frequent, avoidable denial.